U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07136324) titled 'Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry' on Jan. 08, 2021.
Brief Summary: Purpose: The purpose of this registry is to track the clinical outcomes and progression of patients with pancreatic lesions receiving endoscopic ultrasound (EUS)-based radiofrequency ablation (RFA) therapy.
Research Design: This study is a 7-year, single-center prospective registry study with annual follow up. Patients with pancreatic lesions undergoing EUS-guided RFA treatment will be studied. There will be no deviation from standard of care procedures.
Procedures to be Used: Following recruitment into t...